ASCRS Innovation Lecture 2019: A Novel Non-Penetrating Keratoprosthesis as a Solution for Global Corneal Blindness
Yichieh Shiuey, MD and Jose M. Vargas, MD
The KeraKlear Artificial Cornea has not received FDA Clearance
and is limited by U.S. Law to Investigational Use Only
Development of the KeraKlear was Funded in Part by the
US National Institutes of Health and the National Eye Institute
